Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biotechnol ; 157(3): 417-20, 2012 Feb 10.
Article in English | MEDLINE | ID: mdl-22226725

ABSTRACT

The anti-inflammatory drug ibuprofen (Ibu) is metabolized in the human liver to a number of metabolites including 1-hydroxyibuprofen (1-OH-Ibu), 2-OH-Ibu, and 3-OH-Ibu, respectively. The only human CYP known to produce relevant amounts of 3-OH-Ibu is CYP2C9 and as genetic polymorphisms of CYP2C9 influence the metabolization of numerous drugs, the availability of reference standards for CYP2C9-specific metabolites is of considerable interest. The aim of this study was to develop a biological production process for 3-OH-Ibu and to affirm its NMR characteristics. The recombinant fission yeast strain CAD68 coexpressing human CYP2C9 and CPR was used for the whole-cell biotransformation of Ibu to 3-OH-Ibu in 1L batch-scale for 75h. The average space-time yield for the bioproduction of 3-OH-Ibu (125±34µmol/Ld) considerably exceeded that of 2-OH-Ibu (44±10µmol/Ld). Accordingly, average biotransformation activities normalized to dry biomass weight were 5.0±0.8µmol/gd (3-OH-Ibu) and 1.9±0.7µmol/gd (2-OH-Ibu). The metabolite was prepurified on preparative TLC-plates, isolated by HPLC fractionation, and characterized by LC-MS and NMR. As expected, differential fragmentation patterns of 2-OH-Ibu and 3-OH-Ibu were detected in ESI-LC-MS analysis. 44mg of 3-OH-Ibu was efficiently purified from four 1L batch cultures and its structure was clearly confirmed by one- and two-dimensional NMR.


Subject(s)
Aryl Hydrocarbon Hydroxylases/metabolism , Ibuprofen/analogs & derivatives , Ibuprofen/metabolism , Biotransformation , Chromatography, High Pressure Liquid , Cytochrome P-450 CYP2C9 , Humans , Ibuprofen/chemistry , Ibuprofen/isolation & purification , Magnetic Resonance Spectroscopy , Mass Spectrometry , Molecular Structure , Schizosaccharomyces
2.
Chembiochem ; 8(17): 2139-44, 2007 Nov 23.
Article in English | MEDLINE | ID: mdl-17955482

ABSTRACT

Myxalamids are potent inhibitors of the eukaryotic electron transport chain produced by different myxobacteria. Here, we describe the identification of the myxalamid biosynthesis gene cluster from Myxococcus xanthus. Additionally, new myxalamids (5-13) have been obtained by mutasynthesis from bkd mutants of M. xanthus and Stigmatella aurantiaca. Moreover, as these bkd mutants are still able to produce myxalamid B (2), the origin of the isobutyryl-CoA (IB-CoA) starter unit required for its biosynthesis has been determined. In a M. xanthus bkd mutant, IB-CoA originates from valine, but in S. aurantiaca this starter unit is derived from alpha-oxidation of iso-odd fatty acids, thereby connecting primary and secondary metabolism.


Subject(s)
Acyl Coenzyme A/metabolism , Chromatography, High Pressure Liquid , Molecular Structure , Multigene Family , Mutation/genetics , Myxococcus xanthus/enzymology , Myxococcus xanthus/genetics , Polyenes/chemistry , Polyenes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...